We are live on !
Find out more
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Jumia Technologies
JMIA
$798M
| $145K | 0.04% |
+20,512
| New | +$146K |
2026 Q2
0 quarters
|
|
727
Sharplink Inc
SBET
$1.81B
| $140K | 0.03% |
+29,238
| New | +$187K |
2026 Q2
0 quarters
|
|
728
Ocular Therapeutix
OCUL
$1.42B
| $137K | 0.03% |
13,912
-25,082
| -64% | -$227K |
2025 Q1
5 quarters
|
|
729
Lightbridge
LTBR
$191M
| $134K | 0.03% |
+15,265
| New | +$172K |
2026 Q2
0 quarters
|
|
730
Arbutus Biopharma
ABUS
$828M
| $134K | 0.03% |
27,940
-82,183
| -75% | -$361K |
2025 Q1
5 quarters
|
|
731
AGNT Inc
AGNT
$660M
| $128K | 0.03% |
+23,711
| New | +$131K |
2026 Q2
0 quarters
|
|
732
PagSeguro Digital
PAGS
$3.15B
| $126K | 0.03% |
13,926
| – | – |
2024 Q4
6 quarters
|
|
733
Arcos Dorados Holdings
ARCO
$1.7B
| $125K | 0.03% |
15,471
| – | – |
2026 Q1
1 quarter
|
|
734
Holley
HLLY
$302M
| $124K | 0.03% |
+48,574
| New | +$138K |
2026 Q2
0 quarters
|
|
735
Angel Studios
ANGX
$652M
| $124K | 0.03% |
33,683
-10,788
| -24% | -$30.6K |
2026 Q1
1 quarter
|
|
736
NioCorp Developments
NB
$457M
| $121K | 0.03% |
25,198
| – | – |
2025 Q4
2 quarters
|
|
737
Santander
BSBR
$42.5B
| $121K | 0.03% |
+23,084
| New | +$131K |
2026 Q2
0 quarters
|
|
738
ADT
ADT
$4.97B
| $116K | 0.03% |
17,807
| – | – |
2026 Q1
1 quarter
|
|
739
Energy Vault
NRGV
$498M
| $107K | 0.03% |
22,723
-8,567
| -27% | -$38.3K |
2026 Q1
1 quarter
|
|
740
Butterfly Network
BFLY
$1.89B
| $105K | 0.03% |
+12,473
| New | +$64.6K |
2026 Q2
0 quarters
|
|
741
Cytek Biosciences
CTKB
$715M
| $101K | 0.02% |
+22,871
| New | +$97.6K |
2026 Q2
0 quarters
|
|
742
Rezolute
RZLT
$358M
| $101K | 0.02% |
+19,462
| New | +$72.3K |
2026 Q2
0 quarters
|
|
743
Perspective Therapeutics
CATX
$263M
| $101K | 0.02% |
+29,616
| New | +$112K |
2026 Q2
0 quarters
|
|
744
Ivanhoe Electric
IE
$1.35B
| $101K | 0.02% |
10,475
-11,352
| -52% | -$143K |
2025 Q4
2 quarters
|
|
745
Ring Energy
REI
$352M
| $96.3K | 0.02% |
+89,133
| New | +$124K |
2026 Q2
0 quarters
|
|
746
Savara
SVRA
$959M
| $95.8K | 0.02% |
15,554
-58,327
| -79% | -$313K |
2023 Q4
10 quarters
|
|
747
Arhaus
ARHS
$1.55B
| $95.7K | 0.02% |
11,364
-6,636
| -37% | -$46.1K |
2025 Q2
4 quarters
|
|
748
International Tower Hill Mines
THM
$544M
| $95.2K | 0.02% |
+47,829
| New | +$115K |
2026 Q2
0 quarters
|
|
749
CS Disco
LAW
$311M
| $88.2K | 0.02% |
+23,342
| New | +$90.5K |
2026 Q2
0 quarters
|
|
750
Editas Medicine
EDIT
$385M
| $87.3K | 0.02% |
+26,944
| New | +$78.7K |
2026 Q2
0 quarters
|
|
Similar funds
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.